Aerie pharmaceuticals, inc. (AERI)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Dec'12
Assets
Current assets
Cash and cash equivalents

134,179

143,940

248,702

109,363

148,868

202,818

234,954

270,648

249,501

197,569

194,078

242,650

139,534

197,945

211,938

58,519

74,266

91,060

106,946

100,916

113,450

85,586

148,884

27,876

35,843

69,649

4,619

2,925

Short-term investments

130,552

165,250

92,075

-

-

0

1,000

15,455

84,476

52,086

87,256

65,269

68,330

35,717

41,694

48,512

45,023

45,502

48,292

57,873

56,286

54,339

22,177

28,448

29,268

0

-

-

Accounts receivable, net

42,941

38,354

33,278

25,650

14,758

2,715

1,961

1,125

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

20,225

21,054

14,673

10,419

10,192

10,112

5,612

5,747

1,062

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

10,540

7,744

7,940

8,678

6,499

4,530

3,290

2,503

6,115

4,487

2,065

2,057

2,351

4,028

2,910

1,171

1,402

1,865

1,348

1,118

1,219

1,122

656

930

672

618

117

113

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,330

-

Total current assets

338,437

376,342

396,668

154,110

180,317

220,175

246,817

295,478

341,154

254,142

283,399

309,976

210,215

237,690

256,542

108,202

120,691

138,427

156,586

159,907

170,955

141,047

171,717

57,254

65,783

70,267

7,066

3,038

Long-term investments

-

-

5,020

-

-

-

-

-

-

-

901

-

-

-

1,970

5,105

11,480

13,808

7,707

4,140

9,574

18,275

-

249

-

0

-

-

Property, plant and equipment, net

57,223

58,147

58,277

58,595

62,982

60,525

58,360

54,879

47,810

31,932

19,246

14,391

12,532

7,857

4,607

3,844

3,993

3,816

2,912

1,703

796

240

228

160

146

132

114

133

Operating lease right-of-use assets

15,465

16,523

17,216

17,882

16,394

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

1,152

1,596

2,027

3,554

3,357

4,344

4,017

2,604

2,079

4,202

2,656

2,617

2,661

2,707

2,799

2,979

3,037

3,076

8,034

10,587

13,872

273

1,338

39

32

59

62

48

Total assets

412,277

452,608

479,208

234,141

263,050

285,044

309,194

352,961

391,043

290,276

306,202

326,984

225,408

248,254

265,918

120,130

139,201

159,127

175,239

176,337

195,197

159,835

173,283

57,702

65,961

70,458

7,242

3,219

Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable

9,208

12,770

11,480

9,098

11,121

12,403

7,066

8,757

6,066

6,245

-

-

-

5,610

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses and other current liabilities

64,323

65,376

55,728

46,523

35,810

38,381

27,948

20,016

19,070

18,939

18,045

13,265

13,023

13,761

13,547

13,598

15,501

16,565

17,961

17,710

21,852

8,336

6,999

4,846

3,690

3,482

3,175

1,437

Operating lease liabilities

5,614

5,502

5,802

5,494

5,032

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest payable

-

-

-

-

-

-

-

-

-

-

551

545

539

-

551

545

545

551

551

545

539

551

-

-

-

0

504

16

Notes payable, net of discount-related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14,433

2,331

Total current liabilities

79,145

83,648

73,010

61,115

51,963

50,784

35,014

28,773

25,136

25,184

18,596

13,810

13,562

19,371

14,098

14,143

16,046

17,116

18,512

18,255

22,391

8,887

6,999

4,846

3,690

3,482

18,112

3,784

Carrying value

193,833

188,651

183,553

-

-

0

0

123,999

123,922

123,845

123,769

123,692

123,615

123,539

123,463

123,387

123,310

123,236

124,250

124,218

124,187

122,906

124,125

-

-

0

-

-

Long-term operating lease liabilities

10,829

12,102

12,235

13,238

12,044

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-current liabilities

1,261

1,257

1,206

4,030

6,893

6,454

5,598

5,309

5,714

5,648

4,569

4,440

4,115

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrants liability-related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,485

2,456

Total liabilities

285,068

285,658

270,004

78,383

70,900

57,238

40,612

158,081

154,772

154,677

146,934

141,942

141,292

142,910

137,561

137,530

139,356

140,352

142,762

142,473

146,578

131,793

131,124

4,846

3,690

3,482

29,597

6,240

Commitments and contingencies (Note 12)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

61,311

60,898

Stockholders’ equity
Preferred stock, $0.001 par value; 15,000,000 shares authorized as of March 31, 2020 and December 31, 2019; none issued and outstanding

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

Common stock, $0.001 par value; 150,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 46,476,185 and 46,464,669 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

46

46

46

46

46

45

45

40

40

37

36

36

34

33

33

27

27

26

26

25

25

24

24

24

23

23

1

1

Additional paid-in capital

1,072,412

1,062,996

1,050,252

947,246

936,474

924,180

913,499

754,437

740,952

597,318

562,545

555,930

426,597

422,002

415,638

246,070

240,154

236,492

229,670

213,106

209,092

171,326

168,844

166,398

164,008

162,021

1,123

-

Accumulated other comprehensive loss

-120

-92

-158

-

-

0

-1

-9

-157

-28

-98

-81

-105

-68

-13

-10

-68

-179

-32

-41

-58

-107

-9

-13

-21

0

-

-

Accumulated deficit

-945,129

-896,000

-840,936

-791,534

-744,370

-696,419

-644,961

-559,588

-504,564

-461,728

-403,215

-370,843

-342,410

-316,623

-287,301

-263,487

-240,268

-217,564

-197,187

-179,226

-160,440

-143,201

-126,700

-113,553

-101,739

-95,068

-84,790

-63,920

Total stockholders’ equity

127,209

166,950

209,204

155,758

192,150

227,806

268,582

194,880

236,271

135,599

159,268

185,042

84,116

105,344

128,357

-17,400

-155

18,775

32,477

33,864

48,619

28,042

42,159

52,856

62,271

66,976

-83,666

-63,919

Total liabilities and stockholders’ equity

412,277

452,608

479,208

234,141

263,050

285,044

309,194

352,961

391,043

290,276

306,202

326,984

225,408

248,254

265,918

120,130

139,201

159,127

175,239

176,337

195,197

159,835

173,283

57,702

65,961

70,458

7,242

3,219